Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Global analysis of the transcriptional circuitry regulating Candida glabrata biofilm formation

EF 2012-13

Résumé
Due to its intrinsic resistance to commonly used antifungal drugs, Candida glabrata has rapidly grown in prevalence over recent decades and is now second to Candida albicans as the leading cause of fungal infection in humans. Candida species are commensal yeasts commonly associated with the gut microbiota, however, they can cause life-threatening disease in immunocompromised patients. Treatment of infection is hampered by the ability of certain species including C. glabrata to form biofilms on implanted medical devices including urinary and venous catheters, and artificial joints. Biofilms are extremely resistant to both antifungal drugs and mechanical perturbation and once medical devices are infected, they must often be removed to avoid dissemination of the infection into the blood stream as mortality rates approach 50% for invasive Candida infection. The goal of this research is to elucidate the transcriptional programs, including the regulators and their target genes, which allow C. glabrata to form biofilms through genome-wide approaches. This research will reveal the regulatory networks required for C. glabrata biofilm formation and provide key insights into both novel and conserved mechanisms of biofilm development. This research may directly reveal novel therapeutic targets and comprise new treatment strategies that save human lives through the prevention and treatment of fungal biofilms.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
269234
Name
Singh Sheena D
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Global analysis of the transcriptional circuitry regulating Candida glabrata biofilm formation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cellular Signalling; Fungal Evolution; Genomics; Infectious Disease; Microbiology; Molecular Genetics; Transcriptional Regulation
Abstract
Due to its intrinsic resistance to commonly used antifungal drugs, Candida glabrata has rapidly grown in prevalence over recent decades and is now second to Candida albicans as the leading cause of fungal infection in humans. Candida species are commensal yeasts commonly associated with the gut microbiota, however, they can cause life-threatening disease in immunocompromised patients. Treatment of infection is hampered by the ability of certain species including C. glabrata to form biofilms on implanted medical devices including urinary and venous catheters, and artificial joints. Biofilms are extremely resistant to both antifungal drugs and mechanical perturbation and once medical devices are infected, they must often be removed to avoid dissemination of the infection into the blood stream as mortality rates approach 50% for invasive Candida infection. The goal of this research is to elucidate the transcriptional programs, including the regulators and their target genes, which allow C. glabrata to form biofilms through genome-wide approaches. This research will reveal the regulatory networks required for C. glabrata biofilm formation and provide key insights into both novel and conserved mechanisms of biofilm development. This research may directly reveal novel therapeutic targets and comprise new treatment strategies that save human lives through the prevention and treatment of fungal biofilms.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Singh, Sheena D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~